questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Oxidoreductases
NADH, NADPH oxidoreductases
NADH, NADPH oxidoreductases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "NADH, NADPH oxidoreductases : Questions médicales les plus fréquentes",
"headline": "NADH, NADPH oxidoreductases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les NADH, NADPH oxidoreductases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-05",
"dateModified": "2025-04-01",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "NADH, NADPH oxidoreductases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Oxidoreductases",
"url": "https://questionsmedicales.fr/mesh/D010088",
"about": {
"@type": "MedicalCondition",
"name": "Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D010088",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cytochrome reductases",
"alternateName": "Cytochrome Reductases",
"url": "https://questionsmedicales.fr/mesh/D003579",
"about": {
"@type": "MedicalCondition",
"name": "Cytochrome reductases",
"code": {
"@type": "MedicalCode",
"code": "D003579",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.191"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADPH-ferrihemoprotéine reductase",
"alternateName": "NADPH-Ferrihemoprotein Reductase",
"url": "https://questionsmedicales.fr/mesh/D009251",
"about": {
"@type": "MedicalCondition",
"name": "NADPH-ferrihemoprotéine reductase",
"code": {
"@type": "MedicalCode",
"code": "D009251",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.191.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "NADH tetrazolium reductase",
"alternateName": "NADH Tetrazolium Reductase",
"url": "https://questionsmedicales.fr/mesh/D009246",
"about": {
"@type": "MedicalCondition",
"name": "NADH tetrazolium reductase",
"code": {
"@type": "MedicalCode",
"code": "D009246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.530"
}
}
},
{
"@type": "MedicalWebPage",
"name": "NADP transhydrogenases",
"alternateName": "NADP Transhydrogenases",
"url": "https://questionsmedicales.fr/mesh/D009250",
"about": {
"@type": "MedicalCondition",
"name": "NADP transhydrogenases",
"code": {
"@type": "MedicalCode",
"code": "D009250",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.540"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADP transhydrogenase, AB-specific",
"alternateName": "NADP Transhydrogenase, AB-Specific",
"url": "https://questionsmedicales.fr/mesh/D061087",
"about": {
"@type": "MedicalCondition",
"name": "NADP transhydrogenase, AB-specific",
"code": {
"@type": "MedicalCode",
"code": "D061087",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.540.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "NADPH dehydrogenase",
"alternateName": "NADPH Dehydrogenase",
"url": "https://questionsmedicales.fr/mesh/D009252",
"about": {
"@type": "MedicalCondition",
"name": "NADPH dehydrogenase",
"code": {
"@type": "MedicalCode",
"code": "D009252",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Quinone reductases",
"alternateName": "Quinone Reductases",
"url": "https://questionsmedicales.fr/mesh/D011808",
"about": {
"@type": "MedicalCondition",
"name": "Quinone reductases",
"code": {
"@type": "MedicalCode",
"code": "D011808",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.800"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "NADPH dehydrogenase (quinone)",
"alternateName": "NAD(P)H Dehydrogenase (Quinone)",
"url": "https://questionsmedicales.fr/mesh/D016660",
"about": {
"@type": "MedicalCondition",
"name": "NADPH dehydrogenase (quinone)",
"code": {
"@type": "MedicalCode",
"code": "D016660",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.682.608.800.500"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "NADH, NADPH oxidoreductases",
"alternateName": "NADH, NADPH Oxidoreductases",
"code": {
"@type": "MedicalCode",
"code": "D009247",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Fei-Long Li",
"url": "https://questionsmedicales.fr/author/Fei-Long%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China."
}
},
{
"@type": "Person",
"name": "Ye-Wang Zhang",
"url": "https://questionsmedicales.fr/author/Ye-Wang%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "School of Pharmacy, United Pharmaceutical Institute of Jiangsu University and Shandong Tianzhilvye Biotechnology Co. Ltd., Jiangsu University, Zhenjiang 212013, People's Republic of China; College of Petroleum and Chemical Engineering, Beibu Gulf University, Qinzhou 535011, People's Republic of China. Electronic address: zhangyewang@ujs.edu.cn."
}
},
{
"@type": "Person",
"name": "Chuanwu Xia",
"url": "https://questionsmedicales.fr/author/Chuanwu%20Xia",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA."
}
},
{
"@type": "Person",
"name": "Anna L Shen",
"url": "https://questionsmedicales.fr/author/Anna%20L%20Shen",
"affiliation": {
"@type": "Organization",
"name": "McArdle Laboratory for Cancer Research, Department of Oncology, University of Wisconsin School of Medicine and Public Health, Madison, WI, 53706, USA."
}
},
{
"@type": "Person",
"name": "Jung-Ja P Kim",
"url": "https://questionsmedicales.fr/author/Jung-Ja%20P%20Kim",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA. Electronic address: jjkim@mcw.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Integrating particle tracking with computational fluid dynamics to assess haemodynamic perturbation by coronary artery stents.",
"datePublished": "2022-07-28",
"url": "https://questionsmedicales.fr/article/35901129",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0271469"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Diagnostic Performance of Multi-Detector Computed Tomography (MDCT) in Depiction of Acute Spondylodiscitis in an Emergency Department.",
"datePublished": "2022-07-26",
"url": "https://questionsmedicales.fr/article/35894025",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/tomography8040160"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating shear in perfusion rotary lobe pump using nanoparticle aggregates and computational fluid dynamics.",
"datePublished": "2022-07-23",
"url": "https://questionsmedicales.fr/article/35869293",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00449-022-02757-1"
}
},
{
"@type": "ScholarlyArticle",
"name": "Computed tomographic perfusion abnormalities in acute migraine with aura: Characteristics and comparison with transient ischemic attack.",
"datePublished": "2022-07-22",
"url": "https://questionsmedicales.fr/article/36478764",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/23969873221114256"
}
},
{
"@type": "ScholarlyArticle",
"name": "A data-driven machine learning approach for brain-computer interfaces targeting lower limb neuroprosthetics.",
"datePublished": "2022-07-19",
"url": "https://questionsmedicales.fr/article/35966996",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fnhum.2022.949224"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D010088"
},
{
"@type": "ListItem",
"position": 5,
"name": "NADH, NADPH oxidoreductases",
"item": "https://questionsmedicales.fr/mesh/D009247"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : NADH, NADPH oxidoreductases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur NADH, NADPH oxidoreductases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur NADH, NADPH oxidoreductases",
"description": "Comment diagnostiquer une déficience en NADH oxydoréductases ?\nQuels tests sanguins sont utiles pour évaluer NADPH ?\nQuels symptômes indiquent un problème avec ces enzymes ?\nLes tests d'activité enzymatique sont-ils fiables ?\nPeut-on détecter des anomalies génétiques liées à ces enzymes ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Computer+Graphics&page=999#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur NADH, NADPH oxidoreductases",
"description": "Quels sont les symptômes d'une carence en NADH ?\nComment se manifeste une déficience en NADPH ?\nY a-t-il des symptômes neurologiques associés ?\nLes symptômes varient-ils selon l'âge ?\nDes symptômes digestifs peuvent-ils apparaître ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Computer+Graphics&page=999#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur NADH, NADPH oxidoreductases",
"description": "Comment prévenir les déficiences en NADH ?\nY a-t-il des habitudes de vie à adopter ?\nLes bilans de santé réguliers sont-ils utiles ?\nLes vaccinations peuvent-elles jouer un rôle ?\nL'éducation nutritionnelle est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Computer+Graphics&page=999#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur NADH, NADPH oxidoreductases",
"description": "Quels traitements existent pour les déficiences enzymatiques ?\nLa thérapie génique est-elle une option ?\nLes médicaments peuvent-ils aider à réguler ces enzymes ?\nY a-t-il des traitements naturels recommandés ?\nLes transfusions sanguines sont-elles nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Computer+Graphics&page=999#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur NADH, NADPH oxidoreductases",
"description": "Quelles complications peuvent survenir avec une déficience en NADH ?\nLes infections sont-elles une complication fréquente ?\nY a-t-il des risques de maladies chroniques ?\nLes complications cardiovasculaires sont-elles possibles ?\nDes complications hématologiques peuvent-elles survenir ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Computer+Graphics&page=999#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur NADH, NADPH oxidoreductases",
"description": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?\nL'âge est-il un facteur de risque ?\nLe mode de vie influence-t-il le risque ?\nLes maladies génétiques sont-elles un facteur ?\nLe stress oxydatif joue-t-il un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D009247?mesh_terms=Computer+Graphics&page=999#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en NADH oxydoréductases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être utilisés pour diagnostiquer."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utiles pour évaluer NADPH ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages de NADPH et d'autres coenzymes dans le sang peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un problème avec ces enzymes ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, faiblesse musculaire et troubles métaboliques peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Les tests d'activité enzymatique sont-ils fiables ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent utilisés pour évaluer la fonction des NADH et NADPH oxydoréductases."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies génétiques liées à ces enzymes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des tests génétiques peuvent identifier des mutations affectant ces enzymes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en NADH ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, troubles cognitifs et faiblesse musculaire."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une déficience en NADPH ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut se manifester par des infections fréquentes et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en cas de dysfonctionnement enzymatique."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de l'état de santé général."
}
},
{
"@type": "Question",
"name": "Des symptômes digestifs peuvent-ils apparaître ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles digestifs peuvent être liés à des anomalies dans le métabolisme énergétique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les déficiences en NADH ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée riche en nutriments essentiels peut aider à prévenir ces déficiences."
}
},
{
"@type": "Question",
"name": "Y a-t-il des habitudes de vie à adopter ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sain incluant exercice et gestion du stress est recommandé."
}
},
{
"@type": "Question",
"name": "Les bilans de santé réguliers sont-ils utiles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des bilans réguliers peuvent aider à détecter précocement des anomalies enzymatiques."
}
},
{
"@type": "Question",
"name": "Les vaccinations peuvent-elles jouer un rôle ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines vaccinations peuvent prévenir des infections qui aggravent les déficiences."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, comprendre l'importance des nutriments peut aider à prévenir les carences."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences enzymatiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la thérapie génique est explorée pour traiter certaines déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler ces enzymes ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent aider à moduler l'activité des NADH et NADPH oxydoréductases."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels recommandés ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antioxydants et des nutriments peuvent soutenir la fonction enzymatique."
}
},
{
"@type": "Question",
"name": "Les transfusions sanguines sont-elles nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas graves, des transfusions peuvent être nécessaires pour corriger des déficiences."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une déficience en NADH ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques graves et des problèmes neurologiques."
}
},
{
"@type": "Question",
"name": "Les infections sont-elles une complication fréquente ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes avec des déficiences enzymatiques sont plus susceptibles aux infections."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies chroniques ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déficiences peuvent augmenter le risque de maladies chroniques comme le diabète."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles possibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles métaboliques peuvent entraîner des complications cardiovasculaires."
}
},
{
"@type": "Question",
"name": "Des complications hématologiques peuvent-elles survenir ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des anomalies dans le métabolisme peuvent entraîner des complications hématologiques."
}
},
{
"@type": "Question",
"name": "Quels facteurs de risque sont associés aux déficiences enzymatiques ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies métaboliques et une mauvaise nutrition."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines déficiences peuvent être plus fréquentes chez les personnes âgées."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques sont-elles un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques prédisposent aux déficiences en NADH et NADPH."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif joue-t-il un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut aggraver les déficiences enzymatiques et leurs effets."
}
}
]
}
]
}
Coronary artery stents have profound effects on arterial function by altering fluid flow mass transport and wall shear stress. We developed a new integrated methodology to analyse the effects of stent...
Stents were deployed in model vessels followed by tracking of fluorescent particles under flow. Parallel analyses involved high-resolution micro-computed tomography scanning followed by computational ...
Integration of particle tracking with CFD allows assessment of fluid flow and shear stress in stented arteries in unprecedented detail. Deleterious flow perturbations, such as accumulation of particle...
The diagnosis of acute spondylodiscitis can be very difficult because clinical onset symptoms are highly variable. The reference examination is MRI, but very often the first diagnostic investigation p...
We searched our radiological archive for all MRI examinations of patients who had been studied for a suspicion of acute spondylodiscitis in the period between January 2017 and January 2021 (...
MDCT allowed identification of the presence of acute spondylodiscitis in 13 of 25 patients. Specificity and positive predictive value were 100% for MDCT, while sensitivity and negative predictive valu...
The MDCT allows identification of the presence of acute spondylodiscitis in the Emergency Department (ED) with a satisfactory accuracy. In the case of a positive CT examination, this allows therapy to...
Perfusion cell culture technology has gained a lot of interest in recent years in the biopharmaceutical industry. One common application is N-1 perfusion which is used to intensify fed batch productio...
Migraine with aura (MA) accounts for up to 10% of "stroke mimics" and can present cerebral perfusion abnormalities. We aimed to compare perfusion-CT (PCT) findings in acute-onset MA mimicking an ische...
We retrospectively studied patients admitted to our hospital between 2002 and 2014 with suspicion of acute ischemic stroke, having PCT and receiving a final diagnosis of MA. We visually assessed PCT f...
Of 47 patients with MA (median age = 33 years, 55% females), 16 (34%) displayed FHP. Compared to MA patients without FHP, MA patients with FHP had similar headaches and aura features, but a less frequ...
Focal perfusion abnormalities in acute MA often involve adjacent vascular territories and hypoperfusion is less pronounced than in TIA. MA can be best differentiated from TIA by a smaller rMTT increas...
Prosthetic devices that replace a lost limb have become increasingly performant in recent years. Recent advances in both software and hardware allow for the decoding of electroencephalogram (EEG) sign...
The success of the prosthetic rehabilitation is a factor of the periodontal reactions. Hence, in the current study, we aim to assess bone loss in the osseointegrated implants posttreatment by the cone...
We conducted a prospective clinical observational study among 50 subjects who received mandibular dental implants for the replacement of the single lost anterior tooth. The follow-up was done at 1 wee...
We observed a significant variation among the genders and the age groups. The mean bone loss around the implants was statistically significant for the different time intervals (...
Significant bone loss was noted in the first few weeks after implantation. Care should be focused in the initial posttreatment phase to eliminate the factors aggravating the periodontitis....
The role of programmed cell death, especially pyroptosis and apoptosis, in unfavorable immune responses in COVID-19 remains to be elucidated....
We conducted a cross-sectional analysis to investigate the association between the serum gasdermin D (GSDMD) levels, a pyroptotic marker, and caspase-cleaved cytokeratin 18 fragment (M30), an apoptoti...
In this study, 46 patients diagnosed with COVID-19 were divided into the following three groups according to the disease severity: mild to moderate group (n = 10), severe group (n = 14), and critical ...
Higher serum GSDMD levels are associated with critical respiratory status and the consolidation area on chest CT in patients with COVID-19, suggesting that excessive activation of pyroptosis may affec...
The global and ongoing COVID-19 outbreak has compelled the need for timely and reliable methods of detection for SARS-CoV-2 infection. Although reverse transcription-polymerase chain reaction (RT-PCR)...
The PubMed and Google Scholar databases were searched for relevant articles published between 1 January 2020, and 25 April 2021. Exclusion criteria included lack of specification regarding whether the...
The average sensitivity for COVID-19 reported by the high-risk-of-bias studies was 68% [CI: 58, 80; range: 38-96%] for RT-PCR and 91% [CI: 87, 96; range: 47-100%] for CT. The average sensitivity repor...
On average, the high-risk-of bias studies underestimated the sensitivity of RT-PCR and overestimated the sensitivity of CT for COVID-19. Given the incorporation of recently published low-risk-of-bias ...
To investigate aspects of image quality, feasibility and patient comfort in dedicated spiral breast computed tomography (B-CT) in a large patient cohort....
This retrospective study was approved by the institutional review board. 2418 B-CT scans from 1222 women examined between 04/16/2019 and 04/13/2022 were analyzed. Patients evaluated their comfort duri...
Comfort, mobility and usability of the B-CT were rated each with either "no" or "negligible" complaints in >99%. Image quality was rated with "no" or "negligible complaints" in 96.7%. Lesion contrast ...
B-CT provides high image quality and contrast of soft tissue lesions as well as calcifications, while covering the pre-pectoral areas of the breast remains challenging. B-CT is easy to operate for the...
Cutaneous malignant melanoma (CMM) accounts for the highest mortality rate among all skin cancers. Traditional histopathologic diagnosis may be limited by the pathologists' subjectivity. Second-opinio...
We retrospectively examined excisional biopsies of 50 CMM and 20 benign congenital compound nevi. Hematoxylin and eosin (H&E) stained WSI were reviewed independently by two expert dermatopathologists....
The spatial distribution of the nuclei in the sample provided a multi-scale overview of the tumor. A global overview of the lesion's silhouette was achieved and, by increasing the magnification, the t...
In this study we proposed an easy-to-use model that produces segmentations of CMM silhouettes at fine detail level....